Clinical Trial Update: Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

View source ↗

Summary

This clinical trial update notes ongoing recruitment in the United States for real-world use of continuous subcutaneous apomorphine infusion (ONAPGO) to treat P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ONAPGO (APOMORPHINE HYDROCHLORIDE)

Snippet

Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Parkinson Disease | Status: RECRUITING